Assenagon Asset Management
LJPC

Assenagon Asset Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Assenagon Asset Management’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-284,984
Closed -$1.12M – 1082
2019
Q4 		$1.12M Buy
+284,984
New +$1.68M 0.01% 565

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Assenagon Asset Management's LJPC Position: Q1 2020 in Review

Assenagon Asset Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2020, closing a stake of 284,984 shares — an estimated $1.12M sold.

Assenagon Asset Management first reported a position in LJPC in Q4 2019 and held it in 1 quarter. The position peaked at $1.12M in Q4 2019. 73 funds tracked by Wall St. Rank hold LJPC as of Q1 2020.

  • Assenagon Asset Management reported no remaining La Jolla Pharmaceutical Company position as of Q1 2020 after selling out during the quarter.
  • Assenagon Asset Management sold 284,984 La Jolla Pharmaceutical Company shares in Q1 2020, an estimated $1.12M.
  • Assenagon Asset Management first reported a position in La Jolla Pharmaceutical Company in Q4 2019 and held it in 1 quarter.
  • Assenagon Asset Management's La Jolla Pharmaceutical Company position peaked at $1.12M in Q4 2019.
  • 73 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2020.

Based on Assenagon Asset Management's 13F filing for Q1 2020, filed 17 Apr 2020.